| Autor: |
Chybicka, A., Boguslawska-Jaworska, J., Rosinska, B., Weclawek-Tompol, J., Armata, J., Balcerska, A., Balwierz, W., Bubala, H., Drabko, K., Eliasinska, A., Kedziora, M., Sonta-Jakimczyk, D., Sopylo, B., Kolecki, P., Kowalczyk, J., Michał Matysiak, Rokicka-Milewska, R., Stefaniak, M. J., Stanczak, E., Stencel, D., Wysocki, M., Ploszynska, A. |
| Předmět: |
|
| Zdroj: |
ResearcherID |
| Popis: |
Total number of 252 cycles of GM-CSF-Leucomax Sandoz (5 mg/kg/day s.c.) and/or G-CSF Filgrastim Hoffmann-La Roche (5-10 mg/kg/day s.c.) was applied in 124 children aged from 0.5-20 years during neutropenia associated with chemotherapy of non-Hodgkin's lymphoma (NHL). Twenty four children with NHL treated according to the same chemotherapy protocol but without G-CSF and GM-CSF served as a control group. Our study have demonstrated the good efficacy of both G-CSF and GM-CSF therapy. They shortened the period of neutropenia, reduced the number of febrile days, infection's duration and decreased the frequency of infectious complications. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
